Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01101997 · ClinicalTrials.gov registry record · NA
Non-Invasive Reduction of Abdominal Fat
A NA study, sponsored by Zeltiq Aesthetics.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01101997: Completed NA study, sponsored by Zeltiq Aesthetics.
NCT01101997 is a NA study that has completed, run by Zeltiq Aesthetics. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01101997, a NA study, has completed, sponsored by Zeltiq Aesthetics.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study is being performed to reduce unwanted abdominal fat using a new applicator for the Zeltiq System.
Primary Outcome
Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the treated areas. Reviewers will be practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be rand
Interventions
- DEVICE The Zeltiq System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-03-30 |
| Est. Completion | 2010-12-08 |
| Phase | NA |
What the finished NCT01101997 record still lists
NCT01101997 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which The Zeltiq System is the first listed.
NCT01101997 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01101997 about?
NCT01101997 is a clinical study titled "Non-Invasive Reduction of Abdominal Fat". This study is being performed to reduce unwanted abdominal fat using a new applicator for the Zeltiq System.
What is the current status of trial NCT01101997?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2010-03-30. Estimated completion is 2010-12-08.
What interventions are being tested in trial NCT01101997?
The interventions under investigation include: The Zeltiq System (DEVICE).
Who is sponsoring clinical trial NCT01101997?
This trial is sponsored by Zeltiq Aesthetics, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01101997's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI